Page 14 of 15 - Page 14 of 261 - Page 14 - News from 2 | ET HealthWorld (2024)

More from 2

• World Bank sets goal of expanding healthcare to 1.5 billion people by 2030

  ​The development lender said it would deploy financing, its own health expertise and new partnerships with private-sector firms, non-governmental organizations and civil society groups in reaching the target, which it defines as a person receiving treatment by a health care worker through an in-person visit or a telehealth appointment.

• India's Biocon developing its own version of Wegovy, clinical trial likely next year

  ​The Bengaluru-based company, which derives most of its revenue from foreign markets such as the United States, also aims to first launch generic versions of the weight-loss drugs in other emerging markets such as Brazil, Mexico, and Saudi Arabia.

• South Korea set to adjust medical reforms in bid to end walkout, say media reports

  ​President Yoon has been pushing to add more doctors as an integral element of his medical reforms, an idea that has strong public support amid a shortage of physicians outside the greater Seoul area and in essential medical disciplines including emergency care and paediatrics.

• US FDA mandates label updates on CAR-T cancer therapies

  The health regulor has required related updates to other sections of the label such as warnings and precautions, postmarketing experience, patient counseling information and medication guide.

• Cerevel's Parkinson's disease drug improves symptom control in late-stage trial

  The drug developer said it will share additional data from late-stage trials testing the once-daily treatment tavapadon as a monotherapy in the second half of 2024.

• UnitedHealth unit Change Healthcare faces issue processing some medical claims

  The company was still working on resuming operations that were disrupted by the February hack, and on Tuesday said it expects a hit of up to $1.6 billion this year from the cyber attack.

• Weight-loss drug developer Metsera raises $290 million in funding

  Metsera, founded in 2022 by venture capital firm ARCH Venture and investment firm Population Health Partners, is developing injectable and oral drugs to treat obesity, based on the GLP-1 mechanism as well as other biological targets.

• First law protecting consumers' brainwaves signed by Colorado governor

  State representative Cathy Kipp, a sponsor of the legislation, said in a statement that while advancements in the neurotechnology field hold great promise for improving the lives of many people, "we must provide a clear framework to protect Coloradans' personal data from being used without their consent while still allowing these new technologies to develop."

• After COVID, WHO defines disease spread 'through air'

  The Geneva-based U.N. health agency released a technical document on the topic on Thursday. It said it was the first step towards working out how to better prevent this kind of transmission, both for existing diseases like measles and for future pandemic threats.

• FDA classifies recall of Boston Scientific device as 'most serious'

  The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's device used to block blood flow during excessive bleeding or hemorrhaging as "most serious".

• Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says

  Most doses of Eli Lilly's diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand, the U.S. Food and Drug Administration's website showed on Wednesday.